(1R,2S,3S,4S,5R)-2-[(4-fluorophenyl)methylamino]-4-phenylsulfanyl-6,8-dioxabicyclo[3.2.1]octan-3-ol
C19H20FNO3S — CID 162796177
Data last refreshed: (MolForge compound catalog, from PubChem)
About (1R,2S,3S,4S,5R)-2-[(4-fluorophenyl)methylamino]-4-phenylsulfanyl-6,8-dioxabicyclo[3.2.1]octan-3-ol
(1R,2S,3S,4S,5R)-2-[(4-fluorophenyl)methylamino]-4-phenylsulfanyl-6,8-dioxabicyclo[3.2.1]octan-3-ol (PubChem CID 162796177) has the molecular formula C19H20FNO3S and a molecular weight of 361.44 g/mol. Its IUPAC name is (1R,2S,3S,4S,5R)-2-[(4-fluorophenyl)methylamino]-4-phenylsulfanyl-6,8-dioxabicyclo[3.2.1]octan-3-ol.
Molecular Properties
| Compound Name | (1R,2S,3S,4S,5R)-2-[(4-fluorophenyl)methylamino]-4-phenylsulfanyl-6,8-dioxabicyclo[3.2.1]octan-3-ol |
|---|---|
| PubChem CID | 162796177 |
| Molecular Formula | C19H20FNO3S |
| Molecular Weight | 361.44 g/mol |
| Exact Mass | 361.11 |
| IUPAC Name | (1R,2S,3S,4S,5R)-2-[(4-fluorophenyl)methylamino]-4-phenylsulfanyl-6,8-dioxabicyclo[3.2.1]octan-3-ol |
| SMILES | O[C@H]1[C@H](NCc2ccc(F)cc2)[C@@H]2CO[C@H](O2)[C@H]1Sc1ccccc1 |
| InChI | InChI=1S/C19H20FNO3S/c20-13-8-6-12(7-9-13)10-21-16-15-11-23-19(24-15)18(17(16)22)25-14-4-2-1-3-5-14/h1-9,15-19,21-22H,10-11H2/t15-,16+,17-,18-,19+/m0/s1 |
| InChIKey | SHQABHDTMLZFQX-XCDZQEORSA-N |
| XLogP | 2.56 |
| TPSA | 50.72 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 361.44 |
| LogP ≤ 5 | 2.56 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162796177 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.